GCANPharmaceutical PreparationsFiscal year ends December 31Also trades as GCAND
TRAFALGAR INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.14+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.13M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Trafalgar International's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Trafalgar Asset Management, LLC | 7,629,665 | 100.00% | 13D (active) | Jun 29, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Talavera Porfirio Sanchez | CEO, Chairman of the Board, Director, 10% owner | 1,000 | Jul 16, 2026 |
| Aitan Zacharin | Chief Executive Officer, Director, 10% owner | – | Apr 10, 2025 |
| Trafalgar Asset Management, LLC | 10% owner | 1,000 | Jul 16, 2026 |
| LLC Sapir | 10% owner | – | Apr 8, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| LLC Sapir 10% owner | Apr 4, 2025 | Award | +100,000,000 | – | – | – |
| Jimmy Wayne Anderson 10% owner | Dec 2, 2019 | Sale | −176,878 | $0.03 | $5.31K | 6,275,534 |
| Jimmy Wayne Anderson 10% owner | Nov 27, 2019 | Sale | −195,080 | $0.05 | $9.75K | 6,452,412 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.